Title : Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib.

Pub. Date : 2017 Apr 15

PMID : 27702817






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cytotoxicities of cisplatin and the PARP inhibitor rucaparib were assessed using sulforhodamine B (SRB) assays. rucaparib collagen type XI alpha 2 chain Homo sapiens